Nature
2 months agoMedicine
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells - Nature
Tiragolumab combined with atezolizumab shows improved outcomes in cancer treatment
High baseline of intratumoral macrophages and regulatory T cells may lead to better outcomes in patients receiving combination therapy. [ more ]